Viewing Study NCT01762150


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-01-25 @ 11:32 PM
Study NCT ID: NCT01762150
Status: COMPLETED
Last Update Posted: 2018-11-20
First Post: 2012-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
Sponsor: Peking University Cancer Hospital & Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None collected duct carcinoma View
None sorafenib View